Valtoco (Diazepam) Patent Expiration, LOE Window & CMS Spending

Valtoco (Diazepam) by Neurelis: FDA Orange Book LOE 2042-06-10, 11 AB generics, $162.4M 2024 CMS Part D & Medicaid spend, and 6 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorNeurelis
FDA Application & PathwayN211635 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2042-06-10
Orange Book Patents (*PED Extensions)8 patents (0 *PED)
Active AB-Rated Generic Competitors11
2024 CMS Total Public Spend$162.4M
2024 Medicare Part D Spend$24.4M
2024 Medicaid Spend$138.0M
Reported Wholesale Price Change (CA SB 17)6 WAC filings (max 18.5% 2-yr change)